Okklo Life Sciences
  • Company
    • Mission & Vision
    • Management Team
    • Advisors
    • Investors
  • Technology
    • Cyclodextrins
    • Therapeutic CDs
    • OKKLO’s CD Technology
  • Programs
    • Hemostasis
    • Cystic Fibrosis
    • Immunology
    • Lysosomal Storage Disease (NPC)
  • Partnering
  • News
  • Contact
    • Where to meet us
    • Disclaimer
Home » Programs

Programs

Okklo is currently working in a variety of therapeutic areas:

  • Hemostasis (hemophilia and anticoagulant reversal)
  • Cystic fibrosis
  • Immunology (undisclosed target)
  • Lysosomal storage diseases (Niemann-Pick type C disease).

Archive

  • mei 2019
  • juni 2017
  • januari 2017
  • mei 2016
  • november 2014
  • oktober 2014
  • juli 2014
  • mei 2014
  • november 2013
  • september 2013
  • augustus 2013
  • juni 2013
  • maart 2013
  • februari 2013
  • juli 2012
  • Company
  • Technology
  • Programs
  • Partnering
  • News
  • Contact
Copyright © 2016 | Okklo Life Sciences | All Rights Reserved